Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of September:

• Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 at 12:45 pm (EDT)
  
  
• Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024 at 10:45 am (EDT)
  
  
• Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 9:45 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240813897202/en/

Incyte

Media
[email protected]

Investors
[email protected]

Source: Incyte

You May Also Be Interested In

• Incyte (INCY) PT Raised to $112 at BMO Capital
• ITT to Release Second Quarter 2026 Results on Thursday, August 6
• Citizens Financial Group, Inc. Reports Second Quarter 2026 Net Income of $587 Million, up 35% YoY, and EPS of $1.30, up 41% YoY and 15% QoQ